The share of rural Americans who live in communities without a hospital grows each year. It’s part of an ongoing collapse in rural health care that has persisted for decades and isn’t improving, despite regulatory efforts to shore up small-hospital finances.
Sickle Cell Disease patients and the use of disease-modifying treatments
New disease-modifying treatments (DMTs), namely, crizanlizumab, L-glutamine, and voxelotor, have recently been approved.